Groowe Groowe / Newsroom / AGIO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AGIO News

Agios Pharmaceuticals, Inc.

Form 8-K

sec.gov
AGIO

Agios Reports First Quarter 2026 Financial Results and Provides Business Update

globenewswire.com
AGIO

Santhera Appoints Orlando Oliveira as Chief Executive Officer

globenewswire.com
AMGN AGIO CPRX ZENA

Alpha Thalassemia (US, EU4, UK, and Japan) Market Insights, Epidemiology, and Forecasts 2022-2025 & 2025-2036

globenewswire.com
AGIO NVO

Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET

globenewswire.com
AGIO

Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

prnewswire.com
AGIO

AGIO ALERT- The Gross Law Firm Has Commenced an Investigation on Behalf of Agios Pharmaceuticals, Inc. Shareholders Who Lost Money

prnewswire.com
AGIO

PK Activation Gains Momentum in Thalassemia Agios’ Aqvesme Launch Reflects Strong Promise with Deliberate Uptake

globenewswire.com
AGIO

Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA

globenewswire.com
AGIO

AGIO STOCK ALERT: Levi & Korsinsky Notifies Agios Pharmaceuticals, Inc. Investors of an Ongoing Investigation

prnewswire.com
AGIO